The poster communication has been presented in ASEICA 40th anniversary Congress in La Coruña from 14 to 16th november. This work has been the result of a La Marató TV3 project in collaboration with Hospital Germans Trias i Pujol (IGTP) i Institut de Ciències Fotòniques (ICFO).

The results of the poster identified a molecular signature as a prediction biomarkers of therapy in breast cancer patients.

The original title of the poster communication is NR4A1/3 and HBB as new predictive biomarkers of neoadjuvant responses in breast cancer patients.